5VM
ANAB icon

5AM Venture Management’s AnaptysBio ANAB Stock Holding History

5AM Venture Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-357,733
Closed -$6.65M – 30
2025
Q1 		$6.65M Hold
357,733
– – 2.52% 16
2024
Q4 		$4.74M Hold
357,733
– – 1.13% 20
2024
Q3 		$12M Hold
357,733
– – 2.48% 17
2024
Q2 		$8.96M Hold
357,733
– – 2.01% 17
2024
Q1 		$8.06M Hold
357,733
– – 1.8% 17
2023
Q4 		$7.66M Hold
357,733
– – 2.03% 16
2023
Q3 		$6.42M Hold
357,733
– – 1.85% 16
2023
Q2 		$7.28M Hold
357,733
– – 1.81% 16
2023
Q1 		$7.78M Hold
357,733
– – 1.99% 13
2022
Q4 		$11.1M Buy
+357,733
New +$10.1M 2.98% 11

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

5AM Venture Management's ANAB Position: Q2 2025 in Review

5AM Venture Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 357,733 shares — an estimated $6.65M sold.

5AM Venture Management first reported a position in ANAB in Q4 2022 and held it in 10 quarters. The position peaked at $12M in Q3 2024. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

  • 5AM Venture Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
  • 5AM Venture Management sold 357,733 AnaptysBio shares in Q2 2025, an estimated $6.65M.
  • 5AM Venture Management first reported a position in AnaptysBio in Q4 2022 and held it in 10 quarters.
  • 5AM Venture Management's AnaptysBio position peaked at $12M in Q3 2024.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on 5AM Venture Management's 13F filing for Q2 2025, filed 14 Aug 2025.